144 related articles for article (PubMed ID: 35411535)
1. Cycles of Chronic Opioid Therapy Following Mandatory Prescription Drug Monitoring Program Legislation: A Retrospective Cohort Study.
Allen B; Jent VA; Cerdá M
J Gen Intern Med; 2022 Dec; 37(16):4088-4094. PubMed ID: 35411535
[TBL] [Abstract][Full Text] [Related]
2. Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.
Bachhuber MA; Tuazon E; Nolan ML; Kunins HV; Paone D
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):734-739. PubMed ID: 30920062
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
[TBL] [Abstract][Full Text] [Related]
4. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
5. Tracking changes in opioid prescriptions dispensed following the enactment of a prescription drug monitoring program use mandate.
Kaur A; Mott DA; Gilson A
Res Social Adm Pharm; 2023 Dec; 19(12):1543-1550. PubMed ID: 37716901
[TBL] [Abstract][Full Text] [Related]
6. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
[TBL] [Abstract][Full Text] [Related]
7. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children.
Theodorou CM; Jackson JE; Rajasekar G; Nuño M; Yamashiro KJ; Farmer DL; Hirose S; Brown EG
Pediatr Surg Int; 2021 May; 37(5):659-665. PubMed ID: 33433663
[TBL] [Abstract][Full Text] [Related]
8. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
9. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
[TBL] [Abstract][Full Text] [Related]
10. Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City.
Chernick R; Allen B; Harocopos A
J Behav Health Serv Res; 2022 Apr; 49(2):122-133. PubMed ID: 34426933
[TBL] [Abstract][Full Text] [Related]
11. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
[TBL] [Abstract][Full Text] [Related]
12. Mandatory prescription drug monitoring programs and overlapping prescriptions of opioids and benzodiazepines: Evidence from Kentucky.
Nguyen T; Meille G; Buchmueller T
Drug Alcohol Depend; 2023 Feb; 243():109759. PubMed ID: 36621199
[TBL] [Abstract][Full Text] [Related]
13. Provider Compliance With Kentucky's Prescription Drug Monitoring Program's Mandate To Query Patient Opioid History.
Carey CM; Meille G; Buchmueller TC
Health Aff (Millwood); 2021 Mar; 40(3):461-468. PubMed ID: 33646863
[TBL] [Abstract][Full Text] [Related]
14. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
[TBL] [Abstract][Full Text] [Related]
15. Primary care provider perspectives on and utilization of a mandatory prescription drug monitoring program in New York City.
Harocopos A; Allen B; Chernick R
Fam Pract; 2022 Mar; 39(2):264-268. PubMed ID: 34268573
[TBL] [Abstract][Full Text] [Related]
16. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
Martello J; Cassidy B; Mitchell A
J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
[TBL] [Abstract][Full Text] [Related]
17. Prescription drug monitoring program (PDMP) utilization and outcomes within the West Palm Beach Veterans Affairs (VA) healthcare system.
Schroth L; DiScala S; Vartan CM; Forbes H
J Opioid Manag; 2023; 19(2):139-147. PubMed ID: 37270421
[TBL] [Abstract][Full Text] [Related]
18. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
[TBL] [Abstract][Full Text] [Related]
19. Association between prescription drug monitoring programs use mandates and prescription stimulants received by Medicaid enrollees.
Gunadi C; Shi Y
Drug Alcohol Rev; 2023 Nov; 42(7):1658-1666. PubMed ID: 37946605
[TBL] [Abstract][Full Text] [Related]
20. Does prescription drug monitoring program usage affect opioid analgesic prescriptions by oral and maxillofacial surgeons after third molar surgery?
Wang TT; Tong J; Hersh EV; Chuang SK; Panchal N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jul; 132(1):26-31. PubMed ID: 33741285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
